CLINICAL_TRIALS
research
· 2026-01-27
Clinical Trial Update: Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms [NA]
Summary
Berberine is being studied for negative symptoms of schizophrenia, with the trial currently enrolling by invitation and no phase specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia, Negative Symptoms of Schizophrenia | NA | Status: ENROLLING_BY_INVITATION